Increased surface toll-like receptor 2 expression in superantigen shock

Critical Care Medicine

Volumn 36, Issue 4, 2008, Pages 1267-1276

  Hopkins, Philip A ^a   Pridmore, Alison C ^b   Ellmerich, Stephan ^a   Fraser, John D ^c   Russell, Hugh H ^a   Read, Robert C ^b   Sriskandan, Shiranee ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Monocyte; Necrotizing fasciitis; Severe sepsis; Superantigen; Toll like receptor; Toxic shock

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 2; MESSENGER RNA; SUPERANTIGEN; TOLL LIKE RECEPTOR 2;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EX VIVO STUDY; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; INTENSIVE CARE UNIT; LABORATORY TEST; MESSENGER RNA SYNTHESIS; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SEPTIC SHOCK; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SUPERNATANT;

EID: 41649085472     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31816a0a78     Document Type: Article

References (49)

1. Martin GS, Mannino DM, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
2. Kravitz GR, Dries DJ, Peterson ML, et al: Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40:941-947
3. Kengatharan KM, Kimpe SJ, Robson C, et al: Mechanism of Gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 1998; 2:305-315
4. Foster TJ: Immune evasion by staphylococci. Nat Rev Microbiol 2005; 3:948-958
5. Sriskandan S, Faulkner L, Hopkins P: Streptococcus pyogenes: insight into the function of the streptococcal superantigens. Int J Biochem Cell Biol 2007; 39:12-19
6. Stevens DL, Tanner MH, Winship J, et al: Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin. N Eng J Med 1989; 321:1-7
7. Miller LG, Perdreau-Remington F, Rieg G: Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-1453
8. Fenwick P, Ryan C, Sriskandan S, et al: Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med 2003; 31:171-178
9. Sriskandan S, Ferguson M, Elliot V, et al: Human intravenous immunoglobulin for experimental streptococcal toxic shock: Bacterial clearance and modulation of inflammation. J Antimicrob Chemother 2006; 58:117-124
10. Miethke T, Wahl C, Heeg K, et al: T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med 1992; 175:91-97
11. Kotb M, Norrby-Teglund A, McGeer A, et al: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8:1398-1404
12. Llewelyn M, Sriskandan S, Peakman M, et al: HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 2004; 172:1719-1726
13. Faulkner L, Cooper A, Fantino C, et al: The mechanism of superantigen-mediated shock: Not just a Th1 cytokine storm. J Immunol 2006; 175:6870-6877
14. Faulkner L, Altmann DM, Ellmerich S, et al: Sexual diamorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosis. Am J Respir Crit Care Med 2007; 176:473-482
15. Sugiyama H, McKissic EM, Berdoll MS, et al: Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin. J Infect Dis 1964; 114:111-118
16. Blank C, Luz A, Bendigs S, et al: Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol 1997; 27:825-833
17. Beno DW, Uhing MR, Goto M, et al: Chronic Staphylococcal enterotoxin B and lipopolysaccharide induce a bimodal pattern of hepatic dysfunction and injury. Crit Care Med 2003; 31:1154-1159
18. Hopkins PA, Fraser JD, Pridmore AC, et al: Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood 2005; 105:3655-3662
19. Brightbill HD, Libraty DH, Krutzik SR, et al: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285:732-735
20. Underhill DM, Ozinsky A, Hajjar AM, et al: The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811-815
21. Wang JE, Dahle MK, Yndestad A, et al: Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med 2004; 32:546-552
22. Hadley JS, Wang JE, Foster SJ, et al: Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, toll-like receptor 2 (TLR2), and TLR4 in human blood: Possible implications for priming of lipopolysaccharide signaling. Infect Immun 2005; 73:7613-7619
23. Zahringer U, Salvetzki R, Wagner F, et al: Structural and biological characterization of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes. J Endotoxin Res 2001; 7:133-146
24. Schroder NW, Morath S, Alexander C, et al: Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003; 278:15587-15594
25. Tiedemann RE, Fraser JD: Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J Immunol 1996; 157:3958-3966
26. Unnikrishnan M, Cohen J, Sriskandan S: Complementation of a speA negative Streptococcus pyogenes with speA: Effects on virulence and production of streptococcal pyrogenic exotoxin A. Microb Pathog 2001; 31:109-114
27. Unnikrishnan M, Altmann DM, Proft T, et al: The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoreactive agent of Streptococcus pyogenes. J Immunol 2002; 169:2561-2569
28. Pridmore AC, Wyllie DH, Abdillahi F, et al: A lipopolysaccharide- deficient mutant of Neisseria meningitides elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183:89-96
29. Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30:e36
30. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
31. Groenveld AB, Tacx AN, Bossink AW, et al: Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 2003; 106:106-115
32. Latz E, Visintin A, Lien E, et al: Lipopolysaccharide rapidly traffics to and fro from the Golgi apparatus with the toll-like-receptor 4-MD2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 2002; 277:47834-47843
33. Hopkins PA, Sriskandan S: Toll-like receptors: To immunity and beyond. Clin Exp Immunol 2005; 140:395-407
34. Triantafilou M, Gamper FG, Haston RM, et al: Membrane sorting of toll-like receptor (TLR)-2/6 and TLR-2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 2006; 281:31002-31011
35. Chamaillard M, Hashimoto M, Horie Y, et al: An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4:702-707
36. Medvedev AE, Henneke P, Schromm A, et al: Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by over expression of toll-like receptors 2 or 4. J Immunol 2001; 167:2257-2267
37. Calvano JE, Agnese DM, Um JY, et al: Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: Relationship to tolerance. Shock 2003; 20:415-419
38. Becker K, Friedrich AW, Lubritz G, et al: Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 2003; 41:1434-1439
39. Fueyo JM, Mendoza MC, Martin MC: Enterotoxins and toxic shock syndrome toxin in Staphylococcus aureus recovered from human nasal carriers and manually handled foods: Epidemiology and genetic findings. Microbes Infect 2005; 7:187-194
40. Sriskandan S, Moyes D, Cohen J: Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic shock syndrome. Lancet 1996; 348:1315-1316
41. Shimizu T, Tani T, Endo Y, et al: Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: Plasma peptidoglycan reflects bacterial translocation and may affect neutrophil activation. Crit Care Med 2002; 30:77-82
42. Docke WD, Randow F, Syrbe U, et al: Monocyte deactivation in septic patients: Restoration by interferon-gamma treatment. Nat Med 1997; 3:678-681
43. Hershman MJ, Cheadle WG, Wellhausen SR, et al: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77:204-207
44. Suda T, Sato A, Sugiura W, et al: Induction of MHC class II antigens on rat bronchial epithelial cells by interferon-gamma and its effect on antigen presentation. Lung 1995; 173:127-137
45. Aubert V, Schneeberger D, Sauty A, et al: Induction of tumour necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1. Infect Immun 2000; 68:120-124
46. Adib-Conquy M, Moine P, Asehnoune K, et al: Toll-like receptor-mediated tumour necrosis factor and IL-10 production differ during systemic inflammation. Am J Respir Crit Care Med 2003; 168:158-164
47. Ikushima H, Nishida T, Takeda K, et al: Expression of toll-like receptors 2 and 4 is down-regulated after operation. Surgery 2004; 135:376-385
48. Armstrong L, Medford ARL, Hunter KJ, et al: Differential expression of toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 2004; 136:312-319
49. Harter L, Mica L, Stocker R, et al: Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 2004; 22:403-409